ES2162092T3 - Terapia de combinacion para canceres avanzados que comprende temozolomida y cisplatino. - Google Patents

Terapia de combinacion para canceres avanzados que comprende temozolomida y cisplatino.

Info

Publication number
ES2162092T3
ES2162092T3 ES96930553T ES96930553T ES2162092T3 ES 2162092 T3 ES2162092 T3 ES 2162092T3 ES 96930553 T ES96930553 T ES 96930553T ES 96930553 T ES96930553 T ES 96930553T ES 2162092 T3 ES2162092 T3 ES 2162092T3
Authority
ES
Spain
Prior art keywords
cisplatin
combination therapy
advanced cancers
temozolomide
includes temozolomide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96930553T
Other languages
English (en)
Inventor
Margaret H Dugan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ES2162092T3 publication Critical patent/ES2162092T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

SE DESCRIBE UN PROCEDIMIENTO PARA TRATAR EL CANCER AVANZADO EN PACIENTES QUE NECESITEN ESTE TRATAMIENTO. LA TEMOZOLAMIDA Y LA CISPLATINA SE ADMINISTRAN JUNTAS EN CANTIDADES SUFICIENTES PARA LOGRAR UNA RESPUESTA CLINICA.
ES96930553T 1995-08-28 1996-08-26 Terapia de combinacion para canceres avanzados que comprende temozolomida y cisplatino. Expired - Lifetime ES2162092T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US287795P 1995-08-28 1995-08-28
US62479596A 1996-03-27 1996-03-27

Publications (1)

Publication Number Publication Date
ES2162092T3 true ES2162092T3 (es) 2001-12-16

Family

ID=26670993

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96930553T Expired - Lifetime ES2162092T3 (es) 1995-08-28 1996-08-26 Terapia de combinacion para canceres avanzados que comprende temozolomida y cisplatino.

Country Status (11)

Country Link
EP (1) EP0858341B1 (es)
JP (1) JPH10511108A (es)
AT (1) ATE207359T1 (es)
AU (1) AU6955396A (es)
CA (1) CA2229141A1 (es)
DE (1) DE69616367T2 (es)
DK (1) DK0858341T3 (es)
ES (1) ES2162092T3 (es)
GR (1) GR3037047T3 (es)
PT (1) PT858341E (es)
WO (1) WO1997007804A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60120917T2 (de) * 2000-01-26 2007-01-25 Schering Corp. Kombinationspräparat zur krebstherapie
EP1976515A2 (en) * 2006-01-17 2008-10-08 Abbott Laboratories Combination therapy with parp inhibitors
HUE028908T2 (en) 2006-04-05 2017-01-30 Opko Health Inc The hydrochloride salt of 8 - [{1- (3,5-bis (trifluoromethyl) phenyl) ethoxy} methyl] -8-phenyl-1,7-diazaspiro [4.5] decan-2-one, and process
CN103751186B (zh) 2006-04-05 2016-08-24 欧科生医股份有限公司 药物制剂：8-[{1-(3,5-双-(三氟甲基)苯基)-乙氧基}-甲基]-8-苯基-1,7-二氮杂-螺[4.5]癸-2-酮的盐及用其治疗的方法
WO2010081825A2 (en) * 2009-01-13 2010-07-22 Proteosys Ag Pirenzepine as an agent in cancer treatment
EP4090431A4 (en) * 2020-01-13 2024-01-24 Memorial Sloan Kettering Cancer Center Methods and compositions for cancer immunotherapy

Also Published As

Publication number Publication date
JPH10511108A (ja) 1998-10-27
EP0858341A1 (en) 1998-08-19
CA2229141A1 (en) 1997-03-06
DK0858341T3 (da) 2001-11-19
GR3037047T3 (en) 2002-01-31
PT858341E (pt) 2002-03-28
WO1997007804A1 (en) 1997-03-06
EP0858341B1 (en) 2001-10-24
ATE207359T1 (de) 2001-11-15
DE69616367D1 (de) 2001-11-29
MX9801585A (es) 1998-05-31
AU6955396A (en) 1997-03-19
DE69616367T2 (de) 2002-06-27

Similar Documents

Publication Publication Date Title
KR950700749A (ko) 2'-할로메틸리덴 유도체와 S-기 또는 M-기 특이성 항종양제를 사용하는 결합치료에 의한 암치료 방법(Method of treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and a S-phase or M phase specific antineoplastic agent)
PT880350E (pt) Tratamento de esclerose multipla
DK1169059T3 (da) Docetaxel i kombination med rhuMAb HER2 til behandling af cancere
BR9710686A (pt) Método de tratamento de tumores malignos com tiroxinas análogas não possuindo atividade hormonal siginificativa.
EP0719150A4 (en) CELLULAR VACCINE AND METHODS OF USE FOR TREATING MALIGNAS, SOLID TUMORS
PL323798A1 (en) Application of derivatives of vitamin d4 in treating skin diseases
ATE77230T1 (de) Melatoninhaltige mittel sowie deren verwendungen.
NZ504928A (en) Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases
ES2162092T3 (es) Terapia de combinacion para canceres avanzados que comprende temozolomida y cisplatino.
IL121440A0 (en) The use of 1,3,4,6-tetrahydroxy-helianthrone and its derivatives in photodynamic therapy and certain such novel derivatives
CY1105564T1 (el) Θεραπεια συνδυασμου για καρκινο
ES2183977T3 (es) Combinacion de temozolomida y alfa-interferon para el tratamiento de cancer avanzado.
SU1823193A1 (ru) Способ лечения рака гортани
IT1197567B (it) Agente terapeutico contenente pepsina umana,per trattare allergie,malattie da immunocomplessi e tumori
RU94003538A (ru) Способ повышения эффективности лучевой терапии
MX9603833A (es) Tratamiento mejorado del cancer con temozolomida.
UA30257A (uk) Спосіб нормалізації тканинного обміну та відновлення морфофункціонального стану органів і тканин
UA30126A (uk) Спосіб лікування пізнього гестозу вагітних
UA20727A (uk) Спосіб лікуваhhя раку легеhі шляхом хіміоімуhотерапії
RU97114158A (ru) Способ лечения злокачественных опухолей
RU94030259A (ru) Способ лечения рака
UA37542A (uk) Спосіб лікування місцево-поширеного раку молочної залози

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 858341

Country of ref document: ES